Data from this Australian study showed a higher prevalence of intracranial aneurysms (ICAs) in patients with ADPKD compared with the general population. Many patients in the study had no known risk ...
Please provide your email address to receive an email when new articles are posted on . Among patients with autosomal dominant polycystic kidney disease, outcomes were strongly associated with race ...
Please provide your email address to receive an email when new articles are posted on . Patients with autosomal dominant polycystic kidney disease have a preferable cardiac profile before ...
Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic condition that can lead to kidney failure and that has no cure. Recent research published in JASN uncovers an over-looked ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), together with Banner Alzheimer’s Institute, today announced results from the ...
(RTTNews) - Thursday, Vertex Pharmaceuticals Inc. (VRTX) announced that the FDA has cleared the Investigational New Drug Application or IND for VX-407 for the treatment of autosomal dominant ...
A new study published in the Journal of the American Society of Nephrology underscores the importance of the channel protein polycystin-2 in the endoplasmic reticulum (ER) in the maintenance of kidney ...
CALGARY, Alberta, May 05, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a clinical stage pharmaceutical company focused on ...
New research indicates that the polycystin-2 protein in cells' endoplasmic reticulum is important for maintaining kidney health, and its lack can contribute to autosomal dominant polycystic kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results